| Name | Title | Contact Details |
|---|
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Cherry County Hospital is a hospital and healthcare provider.
Dentive is a dental service organization that provides business consulting and services to dentists.
Acure Health Corp. is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Partnering with more than 1,800 physicians at more than 235 outpatient surgery centers across the United States, AmSurg is the nationally recognized leader in the development, management and operation of outpatient surgery centers. AmSurg surgery centers provide high quality, low cost surgical services with superior patient satisfaction. We believe in empowering our physician partners to achieve their professional and personal goals by providing innovative operational, clinical and strategic services.